Cointime

PegBio

company

About

PegBio is a Chinese innovative drug developer.

  • 11 - 50

Highlights

Total Funding Amount
¥7M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
¥7M
Industries
Health Care,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Founded in 2008, Suzhou city-based PegBio is a bio-pharmaceutical company specializing in the development of innovative drugs to combat diabetes and obesity. Its key product PB-119, an agonist of glucagon-like peptide 1 (GLP-1), allows diabetes patients to take medicine once a week, instead of requiring daily injections.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥7M
PegBio has raised a total of ¥7M in funding over 2 rounds. Their latest funding was raised on Oct 15, 2015 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 15, 2015 Series C ¥7M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
PegBio is funded by 1 investors. Mingxin China Growth Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Mingxin China Growth Fund — Series C
Cointime
เนื้อหา
บริษัท